Abexinostat (CRA 024781) is a novel pan-HDAC inhibitor mostly targeting HDAC1 with Ki of 7 nM. Abexinostat also inhibits metallo-beta-lactamase domain-containing protein?2 (MBLAC2) hydrolase activity with an EC50 below 10 nM[1][4].
Molecular Weight:
397.42
Purity:
98.63
CAS Number:
[783355-60-2]
Formula:
C21H23N3O5
Target:
HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted